New Molecular Bioassays for the Estimation of the Teratogenic Potency of Valproic Acid Derivatives in Vitro: Activation of the Peroxisomal Proliferator-Activated Receptor (PPAR )

By Lampen A.   Siehler S.   Ellerbeck U.   Gottlicher M.   Nau H.  

Toxicology and Applied Pharmacology, Vol. 160, Iss. 3, 1999-11 ,pp. : 238-249

Elsevier

Access to resources Recommend Favorite

Molecular modelling of the peroxisome proliferator-activated receptor (PPAR ) from human, rat and mouse, based on homology with the human PPAR crystal structure

By Lewis D.F.V.   Jacobs M.N.   Dickins M.   Lake B.G.  

Toxicology in Vitro, Vol. 16, Iss. 3, 2002-06 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite

Activation of the hsp70 promoter by environmental inorganic and organic chemicals: relationships with cytotoxicity and lipophilicity

By At-Assa S.   Porcher J.-M.   Arrigo A.-P.   Lambre C.  

Toxicology, Vol. 145, Iss. 2, 2000-04 ,pp. : 147-157

Elsevier

Access to resources Recommend Favorite

Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor

By Hong H.  

SAR and QSAR in Environmental Research, Vol. 14, Iss. 5-6, 2003-10 ,pp. : 373-388

Taylor & Francis Ltd

Access to resources Recommend Favorite

Molecular features related to the binding mode of PPARδ agonists from QSAR and docking analyses

By Garcia T.S.   Silva D.C.   Gertrudes J.C.   Maltarollo V.G.   Honorio K.M.  

SAR and QSAR in Environmental Research, Vol. 24, Iss. 2, 2013-02 ,pp. : 157-173

Taylor & Francis Ltd

Access to resources Recommend Favorite